FRI0244 Low Dose of Rituximab Is Effective for Maintenance of Clinical Remission or Low Disease Activity in Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2017-eular.4958
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Identifying Clinical Factors Associated With Low Disease Activity and Remission of Rheumatoid Arthritis During Pregnancy

Arthritis Care and Research
Rheumatology
2017English

Residual Symptoms and Disease Burden Among Patients With Rheumatoid Arthritis in Remission or Low Disease Activity: A Systematic Literature Review

Modern Rheumatology
MedicineRheumatology
2018English

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2020English

Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis

Postgraduate Medical Journal
Medicine
2000English

Intermittent Low Dose Prednisolone Is Safe in Rheumatoid Arthritis

BMJ
1998English

Remission in Rheumatoid Arthritis: Benefit Over Low Disease Activity in Patient-Reported Outcomes and Costs

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

FRI0015 Treating Rheumatoid Arthritis to Target: Is Low Disease Activity Good Enough?

2018English

Maintenance of Remission With Low-Dose Olopatadine Hydrochloride for Itch in Well-Controlled Chronic Urticaria

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy